The Life Science Rundown
By The FDA Group
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by The FDA Group
Category: Life Sciences
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 0
Reviews: 0
Episodes: 38
Description
The Life Science Rundown is a podcast for life science professionals hosted by The FDA Group. We dive deep into topics across the RA/QA/Clinical space, covering news, exploring trends, and picking the brains of expert guests.
| Episode | Date |
|---|---|
|
Crafting Quality Systems for Each Phase of Drug Development with Carlos Yuraszeck
|
Apr 30, 2024 |
|
Leading Through Transition: Strategic Insights from Novartis's Front Lines
|
Apr 01, 2024 |
|
Real Talk on Remote Leadership with Nick Klingensmith
|
Mar 29, 2024 |
|
Audit and FDA Inspection Readiness Best Practices with Divya Gowdar
|
Feb 19, 2024 |
|
Mastering the TMF: Ensuring GCP Compliance and Inspection Readiness with Donna Dorozinsky
|
Feb 05, 2024 |
|
The Startup's Guide to Setting Up Cell Therapy Manufacturing: Navigating Regulations, Resources and Timelines
|
Jan 18, 2024 |
|
A Blueprint for Quality Culture with Vincent Cafiso
|
Dec 19, 2023 |
|
An FDA Inspection Survival Guide with Jonathan Wacks
|
Dec 14, 2023 |
|
Clinical Data Standards in Focus: SDTM Compliance with Sunil Gupta
|
Dec 12, 2023 |
|
The Link Between Quality Culture and QA Communication Pathways with David Marks
|
Nov 15, 2023 |
|
Mastering Medical Device Supplier Management with Paul Hakamaki
|
Nov 09, 2023 |
|
Recent FDA Enforcement Trends with George Toscano
|
Nov 03, 2023 |
|
Growing Your Career in RA/QA with Jessica Smith Beaver, PhD
|
Nov 01, 2023 |
|
Drug Delivery System Innovation and Leadership with Steve Knowles
|
Oct 20, 2023 |
|
Motivating Technical Teams in the Life Sciences: A Conversation with Rick Beatty
|
Oct 09, 2023 |
|
Cross-Cultural Pharma: Mike Martin's Experiences from Puerto Rico to China
|
Aug 14, 2023 |
|
Courageous Leadership to Reinvent Our Healthcare System
|
Jul 27, 2023 |
|
The Critical Role of 'Hyper-Targeting' in Rare Disease Drug Development
|
Jul 14, 2023 |
|
A Journey into Life Sciences Investment: Strategies, Challenges, and Opportunities with Sal Buscemi
|
Jun 01, 2023 |
|
Navigating Risk Management in Medical Devices with Brian Dense
|
May 15, 2023 |
|
The DEA, FDA & Controlled Substances: An Insider's Perspective with Former DEA Agent Dennis Wichern
|
Apr 26, 2023 |
|
A Deep Dive into Medical Device Regulatory Strategy with Regulatory Attorney Christine P. Bump
|
Apr 11, 2023 |
|
Lessons from a Medtech Entrepreneur: Ram Konduru on Fostering Teamwork and Personal Growth in Leadership
|
Apr 03, 2023 |
|
Unlocking Effective Leadership: A Conversation with MetaComet Systems President, David Marlin
|
Mar 24, 2023 |
|
Leadership, Management, and Enhancing Quality of Life: A Conversation with Dan Barker, CEO of Wikimotive
|
Mar 09, 2023 |
|
Navigating the 510(k) Process: A Q&A with Regulatory Consultant, Trey Thorsen, MS, RAC
|
Feb 09, 2023 |
|
The Future of Life Science Talent Acquisition: Securing In-Demand Skills in a Competitive Market
|
Nov 21, 2022 |
|
FDA Revives Its Proposed Quality Metrics Program for Pharma
|
Apr 18, 2022 |
|
Inspection Alternatives Are Driving More FDA Enforcement Actions: What It Means for Industry
|
Feb 14, 2022 |
|
FDA's Domestic Biopharma Inspections Return to Normal
|
Aug 05, 2021 |
|
Quality Management Review: Benchmarking Quantitatively!
|
Jul 02, 2021 |
|
Addressing FDA's Inspection Backlog with Mary Denigan-Macauley, GAO's Director of Health Care
|
Jun 03, 2021 |
|
FDA's Fraudulent Products Task Force and Operation Quack Hack Battle COVID Vaccine Scams
|
Mar 09, 2021 |
|
What to Expect for the FDA's Regulation of Medical Devices & Digital Health Under the Biden Administration
|
Jan 28, 2021 |
|
Clinical Outsourcing & Insourcing: Selecting the Right Model or Mix
|
Jan 11, 2021 |
|
What RA/QA/Clinical Leaders Should Expect From the FDA in 2021
|
Dec 16, 2020 |
|
Inside FDA Pre-Approval Inspections with Former FDA Investigator, Christopher Smith
|
Nov 12, 2020 |
|
A Look at FDA's Pandemic Inspections Q&A Guidance
|
Nov 12, 2020 |